Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is
closely related to advanced liver disease. Cirrhosis represents the greatest risk factor for this …

Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
third most common cause of cancer-related deaths; the number of new cases per year is …

Objective: We compared surgical resection (SR) and radiofrequency ablation (RFA) as first-
line treatment in patients with hepatocellular carcinoma (HCC) based on the risk of …

Background & Aims This study aimed to identify preoperative magnetic resonance (MR)
imaging biomarkers for predicting microvascular invasion (MVI), to determine their …

BACKGROUND & AIMS: The aim of this study was to generate an improved prognostic
model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma …

The diagnosis and treatment of hepatocellular carcinoma (HCC) have witnessed major
changes over the past decade. Until the early 1990s, HCC was a relatively rare malignancy …

Surveillance programs in cirrhotic patients enable the detection of hepatocellular carcinoma
(HCC) at early stages, when the tumor is amenable to curative treatments (60% of cases in …

Background Accurate identification of microvascular invasion (MVI) in hepatocellular
carcinoma (HCC) before treatment is critical for selecting a proper treatment strategy …

Vascular invasion and high histologic grade predict poor outcome after surgical resection or
liver transplantation for hepatocellular carcinoma (HCC). Despite the known association …

Background: Needle biopsy of a suspicious liver lesion could guide management in the
setting of equivocal imaging and serology, although it is not recommended generally …